You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-SCD1 antibody [CD.E10] (ab19862)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab19862? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab19862 has been referenced in 7 publications.

  1. Yu Y et al. Human cytomegalovirus infection induces adipocyte-like lipogenesis through activation of sterol regulatory element binding protein 1. J Virol 86:2942-9 (2012). WB; Human. PubMed: 22258239
  2. Fritz V et al. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol Cancer Ther 9:1740-54 (2010). ICC/IF, IHC-P; Human. PubMed: 20530718
  3. Ecker J et al. Lower SCD expression in dendritic cells compared to macrophages leads to membrane lipids with less mono-unsaturated fatty acids. Immunobiology 215:748-55 (2010). PubMed: 20579763
  4. Hellemans KH et al. Susceptibility of pancreatic beta cells to fatty acids is regulated by LXR/PPARalpha-dependent stearoyl-coenzyme A desaturase. PLoS One 4:e7266 (2009). WB; Rat. PubMed: 19787047
  5. Peter A et al. Individual stearoyl-coa desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes 58:1757-65 (2009). PubMed: 19478146
  6. Peter A et al. Induction of stearoyl-CoA desaturase (SCD-1) protects human arterial endothelial cells against lipotoxicity. Am J Physiol Endocrinol Metab : (2008). PubMed: 18523127
  7. Yao-Borengasser A et al. Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness. J Clin Endocrinol Metab 93:4431-9 (2008). WB; Human. PubMed: 18697866

Publishing research using ab19862? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"